Will Evidence-based Medicine Survive the COVID-19 Pandemic?

Ann Am Thorac Soc. 2020 Sep;17(9):1060-1061. doi: 10.1513/AnnalsATS.202006-587ED.

Authors

Ary Serpa Neto^{1

2}, Carol Hodgson^{1

3}

Affiliations

¹ Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
² Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil; and.
³ Department of Intensive Care, Alfred Health, Melbourne, Victoria, Australia.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adult
Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections* / drug therapy
Evidence-Based Medicine
Humans
Hydroxychloroquine
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Hydroxychloroquine